Richard Daniell

Exec. VP, European Commercial

Richard Daniell (Exec. VP, European Commercial) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $4.2M of TEVA (128,985 sh across 2 lots, as filed), executed Mar 3.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$12.1M

shares × price, as filed

Last traded

May 5

Filed May 7

Median ADV $196.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $16.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

TEVA

Teva Pharmaceutical Industries Limited TEVA · 0 buys · 8 sells 8 filings

Recent filings

TEVASALE Teva Pharmaceutical Industries Limited View filing → $1.1M
30,000 sh × $35.40
Exec May 5
Filed May 7 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $548K
17,295 sh × $31.67
Exec Mar 5
Filed Mar 9 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $3.0M
91,345 sh across 3 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $4.2M
128,985 sh across 2 lots
Exec Mar 3
Filed Mar 5 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $3.3M
115,468 sh × $28.68
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $1.1M
70,961 sh across 2 lots
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $2.2M
140,372 sh across 6 lots
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $1000K
62,250 sh across 2 lots
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET